Trial Site Detail

 

Drug:
Sorafenib (Nexavar, BAY 43-9006)
Trial:
Sorafenib in Treating Patients With Malignant Gastrointestinal Stromal Tumor That Progressed During or After Previous Treatment With Imatinib Mesylate and Sunitinib Malate
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Ongoing, but not recruiting

 

Cancer Care Specialists

2880 N. Monroe     
Decatur , IL 62526
USA

 

Principal Investigator:
 James Wade III, MD
Contact:
 James Wade III, MD, 217-876-6617, jlwade3@sbcglobal.net
Activation Status of this Site:
 Closed
Notes about this Site:
Cancer Care Specialists Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.